Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic.

Hotez, Peter J; Batista, Carolina; Amor, Yanis Ben; Ergonul, Onder; Figueroa, J Peter; Gilbert, Sarah; Gursel, Mayda; Hassanain, Mazen; Kang, Gagandeep; Kaslow, David C; Kim, Jerome H; Lall, Bhavna; Larson, Heidi; Naniche, Denise; Sheahan, Timothy; Shoham, Shmuel; Wilder-Smith, Annelies; Sow, Samba O; Strub-Wourgaft, Nathalie; Yadav, Prashant; ... (2021). Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic. EClinicalMedicine, 39, p. 101053. Elsevier 10.1016/j.eclinm.2021.101053

[img]
Preview
Text
Hotez_EClinicalMedicine_2021.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (868kB) | Preview

A Lancet Commission for COVID-19 task force is shaping recommendations to achieve vaccine and therapeutics access, justice, and equity. This includes ensuring safety and effectiveness harmonized through robust systems of global pharmacovigilance and surveillance. Global production requires expanding support for development, manufacture, testing, and distribution of vaccines and therapeutics to low- and middle-income countries (LMICs). Global intellectual property rules must not stand in the way of research, production, technology transfer, or equitable access to essential health tools, and in context of pandemics to achieve increased manufacturing without discouraging innovation. Global governance around product quality requires channelling widely distributed vaccines through WHO prequalification (PQ)/emergency use listing (EUL) mechanisms and greater use of national regulatory authorities. A World Health Assembly (WHA) resolution would facilitate improvements and consistency in quality control and assurances. Global health systems require implementing steps to strengthen national systems for controlling COVID-19 and for influenza vaccinations for adults including pregnant and lactating women. A collaborative research network should strive to establish open access databases for bioinformatic analyses, together with programs directed at human capacity utilization and strengthening. Combating anti-science recognizes the urgency for countermeasures to address a global-wide disinformation movement dominating the internet and infiltrating parliaments and local governments.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

UniBE Contributor:

Wilder-Smith, Annelies

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

2589-5370

Publisher:

Elsevier

Language:

English

Submitter:

Andrea Flükiger-Flückiger

Date Deposited:

20 Aug 2021 11:07

Last Modified:

04 Jan 2023 10:52

Publisher DOI:

10.1016/j.eclinm.2021.101053

PubMed ID:

34368661

Uncontrolled Keywords:

COVID-19 Health equity Vaccine distribution global governance public health justice public health security therapeutics vaccine access vaccine development vaccine technologies

BORIS DOI:

10.48350/158360

URI:

https://boris.unibe.ch/id/eprint/158360

Actions (login required)

Edit item Edit item
Provide Feedback